Literature DB >> 15068825

The science behind lutein.

Alexandra Alves-Rodrigues1, Andrew Shao.   

Abstract

In humans, as in plants, the xanthophyll lutein is believed to function in two important ways: first as a filter of high energy blue light, and second as an antioxidant that quenches and scavenges photo induced reactive oxygen species (ROS). Evidence suggests that lutein consumption is inversely related to eye diseases such as age-related macular degeneration (AMD) and cataracts. This is supported by the finding that lutein (and a stereo isomer, zeaxanthin) are deposited in the lens and the macula lutea, an area of the retina responsible for central and high acuity vision. Human intervention studies show that lutein supplementation results in increased macular pigment and improved vision in patients with AMD and other ocular diseases. Lutein may also serve to protect skin from UV-induced damage and may help reduce the risk of cardiovascular disease. Crystalline lutein is readily absorbed from foods and from dietary supplements whereas, to enter the bloodstream, lutein esters require prior de-esterification by intestinal enzymes. Unlike the hydrocarbon carotenoids which are mainly found in the LDL fraction, xanthophylls like lutein and zeaxanthin are incorporated into both HDL and LDL. Today, lutein can be obtained from the diet in several different ways, including via supplements, and most recently in functional foods. Animal toxicology studies have been performed to established lutein's safety as a nutrient. These studies have contributed to the classification of purified crystalline lutein as generally recognized as safe (GRAS). The achievement of GRAS status for purified crystalline lutein allows for the addition of this form into several food and beverage applications. This achievement speaks directly to the quality and safety of purified lutein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15068825     DOI: 10.1016/j.toxlet.2003.10.031

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  47 in total

1.  ["Do you have a remedy for macular degeneration?" A field study about the advice given on dietary supplementation in 60 German pharmacies].

Authors:  F Ziemssen; M Warga; K U Bartz-Schmidt; H Wilhelm
Journal:  Ophthalmologe       Date:  2005-07       Impact factor: 1.059

2.  The effect of OPC Factor on energy levels in healthy adults ages 45-65: a phase IIb randomized controlled trial.

Authors:  Patrick J LaRiccia; John T Farrar; Mary D Sammel; Joseph J Gallo
Journal:  J Altern Complement Med       Date:  2008-07       Impact factor: 2.579

3.  Lutein modulates transcription dysregulation of adhesion molecules and spermatogenesis transcription factors induced by testicular ischemia reperfusion injury: it could be SAFE.

Authors:  May Al-Maghrebi; Waleed M Renno; Hoda F Al-Somali; Marina S Botras; Iman N Qadhi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02-26       Impact factor: 3.000

4.  [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].

Authors:  M Zeimer; H W Hense; B Heimes; U Austermann; M Fobker; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2009-01       Impact factor: 1.059

5.  Protective effects of various antioxidants during ischemia-reperfusion in the rat retina.

Authors:  Nihat Dilsiz; Ayse Sahaboglu; M Zulfu Yildiz; Andreas Reichenbach
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-05       Impact factor: 3.117

Review 6.  Vertebrate and invertebrate carotenoid-binding proteins.

Authors:  Prakash Bhosale; Paul S Bernstein
Journal:  Arch Biochem Biophys       Date:  2006-10-30       Impact factor: 4.013

7.  Lutein protects RGC-5 cells against hypoxia and oxidative stress.

Authors:  Suk-Yee Li; Amy C Y Lo
Journal:  Int J Mol Sci       Date:  2010-05-11       Impact factor: 5.923

Review 8.  [Lutein and antioxidants in the prevention of age-related macular degeneration].

Authors:  M Rehak; E Fric; P Wiedemann
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

Review 9.  Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications.

Authors:  Ana Gabriela Murillo; Maria Luz Fernandez
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

10.  Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes.

Authors:  M Sasaki; Y Ozawa; T Kurihara; S Kubota; K Yuki; K Noda; S Kobayashi; S Ishida; K Tsubota
Journal:  Diabetologia       Date:  2010-02-17       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.